login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
TVARDI THERAPEUTICS INC (TVRD) Stock News
USA
- NASDAQ:TVRD -
US1407553072
-
Common Stock
4.19
USD
+0.17 (+4.23%)
Last: 11/10/2025, 8:00:02 PM
4.19
USD
0 (0%)
After Hours:
11/10/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TVRD Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Faruqi & Faruqi LLP
TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
5 days ago - By: Faruqi & Faruqi, LLP
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
6 days ago - By: Schall Law
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
7 days ago - By: Faruqi & Faruqi LLP
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
7 days ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
8 days ago - By: Faruqi & Faruqi, LLP
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
10 days ago - By: The Schall Law Firm
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
12 days ago - By: Faruqi & Faruqi LLP
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
14 days ago - By: Faruqi & Faruqi, LLP
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
16 days ago - By: Faruqi & Faruqi LLP
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
17 days ago - By: The Rosen Law Firm, P.A.
Rosen Law Firm Encourages Tvardi Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – TVRD
19 days ago - By: Faruqi & Faruqi, LLP
Faruqi & Faruqi Reminds Tvardi Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 3, 2025 - TVRD
a month ago - By: Faruqi & Faruqi, LLP
TVRD SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
a month ago - By: Benzinga
- Mentions:
SSII
DBVT
NDRA
RCKT
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
a month ago - By: Faruqi & Faruqi, LLP
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
a month ago - By: Benzinga
Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks
a month ago - By: Stocktwits
- Mentions:
IWO
UWM
Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today?
a month ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis
3 months ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
3 months ago - By: The Motley Fool
Tvardi Posts Q2 Net Income Turnaround
3 months ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update
4 months ago - By: Yahoo Finance
- Mentions:
NVDA
AMD
TSLA
This ‘Strong Buy’ Stock Could Be the Next Big Biotech Breakout
4 months ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
5 months ago - By: Yahoo Finance
- Mentions:
AVGO
VZ
CRWD
LULU
...
1 Stock to Buy, 1 Stock to Sell This Week: Broadcom, Lululemon
5 months ago - By: Yahoo Finance
- Mentions:
BRKA
BRKB
VRTX
PLD
...
2 Top Stocks to Buy Right Now
5 months ago - By: Yahoo Finance
- Mentions:
VYGR
BIDU
AGYS
LCID
...
Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks
6 months ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
6 months ago - By: Yahoo Finance
- Mentions:
UNH
HD
AZO
HSBC
...
UnitedHealth downgraded, Home Depot upgraded: Wall Street's top analyst calls
6 months ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
6 months ago - By: Tvardi Therapeutics, Inc.
Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update
Please enable JavaScript to continue using this application.